Registry Data Suggest TaTME Is Safe and Effective for Rectal Cancer
The 2-year actuarial rate of local recurrence was 4.8%.
Rectal Cancer
Colorectal Cancer: What Your Patients Need to Know
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
Disease Recurrence Risk for Patients With Rectal Cancer Followed With “Watch and Wait”
The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.
Rectal Cancer Treatment Regimens
Get the latest treatment options for rectal cancer, including concurrent chemotherapy and radiotherapy and levoleucovorin plus 5-FU.
ASTRO Issues Guideline on Radiation Therapy for Rectal Cancer
Neoadjuvant RT recommended for stage II to III rectal cancer; RT should be performed preoperatively.
More Support for “Watch-and-Wait” Approach in Subgroup of Patients With Resectable Rectal Cancer
Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
Comparing Long-Course Chemoradiation With Short-Course Radiation Therapy in Rectal Cancer
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
Adherence to Topical Management of Hand-Foot Skin Reaction Poor Among Patients Treated With Regorafenib
Researchers sought to measure adherence to topical management regimens among patients with HFSR due to treatment with regorafenib.
Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
A retrospective review of data from the National Cancer Data Base demonstrated that trends in rectal cancer may follow a pattern similar to that of colon cancer.
Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
Incidence of colon and rectal cancers are increasing sharply in people younger than 50 years, the recommended age for initiating screening.
- Loading...
Loading...
Next post in Colorectal Cancer
Loading... 
Loading...